Skip to Content
Merck
  • Central diabetes insipidus in an HHV6 encephalitis patient with a posterior pituitary lesion that developed after tandem cord blood transplantation.

Central diabetes insipidus in an HHV6 encephalitis patient with a posterior pituitary lesion that developed after tandem cord blood transplantation.

Internal medicine (Tokyo, Japan) (2013-05-17)
Shinichiro Kawamoto, Kazuo Hatanaka, Masami Imakita, Toshiharu Tamaki
ABSTRACT

A 60-year-old myelodysplastic syndrome patient underwent tandem cord blood transplantation. The primary cord blood graft was rejected, and human herpesvirus 6 (HHV6) encephalitis developed after engraftment of secondary cord blood. Polyuria and adipsic hypernatremia were observed during treatment of the encephalitis. The patient died of bacteremia caused by methicillin-resistant Streptococcus epidermis. HHV6 infection in the posterior pituitary was confirmed on autopsy, as was infection of the hippocampus, but not of the hypothalamus. This is the first case report of central diabetes insipidus caused by an HHV6 posterior pituitary infection demonstrated on a pathological examination.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Herpes Virus 6 Antibody, 101kDa protein, clone C3108-103, clone C3108-103, Chemicon®, from mouse